Results 171 to 180 of about 81,441 (250)

Coronary Artery Calcium Score Predicts Cardiovascular and Transplant‐Related Outcomes in Lung Transplant Recipients

open access: yesClinical Transplantation, Volume 40, Issue 6, June 2026.
ABSTRACT Introduction Current guidelines recommend evaluation for coronary artery disease prior to lung transplantation. Coronary artery calcium scores obtained using non‐gated, non‐contrast computed tomography scans may help predict major adverse cardiovascular events following transplant.
Daniel N. Cook   +6 more
wiley   +1 more source

CYP2C19 Polymorphism and Platelet Aggregation‐Associated Risks in Atrial Fibrillation Patients Undergoing PCI

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT CYP2C19 genetic polymorphisms impact the antiplatelet effect of clopidogrel and associate with ischemic and bleeding risk in patients undergoing percutaneous coronary intervention (PCI). This study aimed to evaluate the association of CYP2C19 and platelet reactivity (PR) with these risks, in atrial fibrillation (AF) patients undergoing PCI ...
Diona Gjermeni   +12 more
wiley   +1 more source

Timely Primary Percutaneous Coronary Intervention

open access: yesJACC: Cardiovascular Interventions, 2015
openaire   +1 more source

Obstructive sleep apnoea is associated with accelerated progression of diabetic kidney disease

open access: yesDiabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aim Persons with type 2 diabetes and diabetic kidney disease (DKD) are at high risk of end‐stage kidney disease or death. We investigated the possible contribution of obstructive sleep apnoea (OSA) to decline in kidney function and renal outcomes.
Sebastian Nielsen   +9 more
wiley   +1 more source

Single catheter primary percutaneous coronary intervention method in patients with ST-elevation myocardial infarction: the SPEEDY-PCI study. [PDF]

open access: yesCardiovasc Interv Ther
Torii S   +18 more
europepmc   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna   +10 more
wiley   +1 more source

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 6, June 2026.
In 1969, consecutive patients undergoing CMR, MAD was assessed in end‐diastole and end‐systole across 2‐, 3‐, and 4‐chamber views (panels A–F, lower left), and native T1 relaxation times were measured at the mitral annulus (upper left, T1 colour map).
Katharina Mascherbauer   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy